| 產(chǎn)品編號(hào) | 圖片 | CAS No. | 名稱及描述 | 規(guī)格 | 價(jià)格 | 分子式 | 快速訂購 |
|---|---|---|---|---|---|---|---|
| 201103-25MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(4-硝基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C33H29N2O8P | |
| 201102-1G |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(4-硝基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C33H29N2O8P | |
| 201102-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(4-硝基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C33H29N2O8P | |
| 201102-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(4-硝基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C33H29N2O8P | |
| 201101-1G |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(4-甲氧基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C35H35O6P | |
| 201101-100MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(4-甲氧基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C35H35O6P | |
| 201101-25MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(4-甲氧基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C35H35O6P | |
| 201100-1G |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(4-甲氧基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C35H35O6P | |
| 201100-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(4-甲氧基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C35H35O6P | |
| 201100-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(4-甲氧基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(4-methoxyphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C35H35O6P | |
| 201099-1G |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(4-三氟甲基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C35H29F6O4P | |
| 201099-100MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(4-三氟甲基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C35H29F6O4P | |
| 201099-25MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(4-三氟甲基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C35H29F6O4P | |
| 201098-1G |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(4-三氟甲基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C35H29F6O4P | |
| 201098-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(4-三氟甲基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C35H29F6O4P | |
| 201098-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(4-三氟甲基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C35H29F6O4P | |
| 201097-1G |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(4-叔丁基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis((4-(1,1-dimethylethyl)phenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C41H47O4P | |
| 201097-100MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(4-叔丁基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis((4-(1,1-dimethylethyl)phenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C41H47O4P | |
| 201097-25MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(4-叔丁基苯基)螺環(huán)二酚磷酸酯 (11aS)-3,7-Bis((4-(1,1-dimethylethyl)phenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價(jià) | C41H47O4P | |
| 201096-1G |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(4-叔丁基苯基)螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis((4-(1,1-dimethylethyl)phenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價(jià) | C41H47O4P | |
小泰
|
010-60710855
|